Shanghai Desano
Shanghai, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
✓ MHRA GMP (3)
✓ HC GMP (2)
Quick Facts: Shanghai Desano
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Shanghai, China
- Website
- https://www.desano.com/
- Modalities
- Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Shanghai Desano
Shanghai Desano makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide. 2 manufacturing sites registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.desano.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Shanghai Desano FDA Inspection History
2024-10
2023-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-10-18 |
Shanghai Desano Bio-Pharmaceutical Co., Ltd.
Shanghai
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2023-11-17 |
Shanghai Desano Chemical Pharmaceutical Co., Ltd.
Pudong District
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Shanghai Desano MHRA GMP Compliance 3 certificates
2017-03
2017-03
2017-03
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK API 39359 Insp GMP 39359/2460457-0001 [H] | SHANGHAI DESANO CHEMICAL PHARMACEUTICAL COMPANY LIMITED | CN 201302 | 2017-03-06 | COMPLIANT |
| UK API 39359 Insp GMP 39359/2460457-0001 [V] | SHANGHAI DESANO CHEMICAL PHARMACEUTICAL COMPANY LIMITED | CN 201302 | 2017-03-06 | COMPLIANT |
| UK API 39359 Insp GMP 39359/2460457-0002 | SHANGHAI DESANO CHEMICAL PHARMACEUTICAL COMPANY LIMITED | CN 201302 | 2017-03-06 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Shanghai Desano
How many FDA inspections does Shanghai Desano have on record?
CDMO Signal tracks 2 FDA inspections for Shanghai Desano, sourced from the FDA inspection database. See the full inspection history above.
Has Shanghai Desano received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Shanghai Desano.
Does Shanghai Desano hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 MHRA GMP certificates for Shanghai Desano.
Does Shanghai Desano have a CDMO Signal Score?
Not yet. Shanghai Desano is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Shanghai Desano for a manufacturing program?
Use the free AI matchmaker to compare Shanghai Desano against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
PharmaBlock
Nanjing, Jiangsu, China
Small Molecule API, Intermediates, Oral Solid Dose
Viwit Pharmaceutical
Zaozhuang, Shandong, China
Small Molecule API, Intermediates, Oral Solid Dose, Sterile Injectables
Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose
Zhejiang Huahai Pharmaceutical
Linhai, Zhejiang, China
Small Molecule API, Intermediates, Oral Solid Dose, Lyophilization, Packaging & Labeling
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Compare Shanghai Desano with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.